133 related articles for article (PubMed ID: 16098296)
1. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
Nikolsky E; Sadeghi HM; Effron MB; Mehran R; Lansky AJ; Na Y; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD; Grines CL; Stone GW
Am J Cardiol; 2005 Aug; 96(4):474-81. PubMed ID: 16098296
[TBL] [Abstract][Full Text] [Related]
2. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
[TBL] [Abstract][Full Text] [Related]
4. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
[TBL] [Abstract][Full Text] [Related]
5. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
Nikolsky E; Grines CL; Cox DA; Garcia E; Tcheng JE; Sadeghi M; Mehran R; Lansky AJ; Na Y; Stone GW
Am J Cardiol; 2007 Apr; 99(8):1055-61. PubMed ID: 17437727
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Lansky AJ; Pietras C; Costa RA; Tsuchiya Y; Brodie BR; Cox DA; Aymong ED; Stuckey TD; Garcia E; Tcheng JE; Mehran R; Negoita M; Fahy M; Cristea E; Turco M; Leon MB; Grines CL; Stone GW
Circulation; 2005 Apr; 111(13):1611-8. PubMed ID: 15811868
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.
Cote AV; Berger PB; Holmes DR; Scott CG; Bell MR
Mayo Clin Proc; 2001 Sep; 76(9):890-6. PubMed ID: 11560299
[TBL] [Abstract][Full Text] [Related]
9. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
Barthélémy O; Silvain J; Brieger D; Mercadier A; Lancar R; Bellemain-Appaix A; Beygui F; Collet JP; Costagliola D; Montalescot G
Catheter Cardiovasc Interv; 2012 Jan; 79(1):104-12. PubMed ID: 22162411
[TBL] [Abstract][Full Text] [Related]
10. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
[TBL] [Abstract][Full Text] [Related]
11. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
12. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
[TBL] [Abstract][Full Text] [Related]
13. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
Nikolsky E; Mehran R; Sadeghi HM; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2009 Jul; 2(7):624-32. PubMed ID: 19628185
[TBL] [Abstract][Full Text] [Related]
15. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Pellizzon GG; Grines CL; Cox DA; Stuckey T; Tcheng JE; Garcia E; Guagliumi G; Turco M; Lansky AJ; Griffin JJ; Cohen DJ; Aymong E; Mehran R; O'Neill WW; Stone GW
J Am Coll Cardiol; 2004 Apr; 43(8):1368-74. PubMed ID: 15093869
[TBL] [Abstract][Full Text] [Related]
16. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.
Sadeghi HM; Stone GW; Grines CL; Mehran R; Dixon SR; Lansky AJ; Fahy M; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD
Circulation; 2003 Dec; 108(22):2769-75. PubMed ID: 14638545
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction.
Nikolsky E; Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Negoita M; Lansky AJ; Mehran R
Am Heart J; 2006 Jan; 151(1):168-75. PubMed ID: 16368312
[TBL] [Abstract][Full Text] [Related]
19. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
20. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).
Stuckey TD; Stone GW; Cox DA; Tcheng JE; Garcia E; Carroll J; Guagliumi G; Rutherford BD; Griffin JJ; Turco M; Lansky AJ; Mehran R; Fahy M; Brodie BR; Grines CL;
Am J Cardiol; 2005 Jan; 95(1):1-7. PubMed ID: 15619385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
